Orabi, K. 2013. Microbial Metabolism of Rofecoxib, A Selective COX-2 Inhibitor. International Journal of Biotechnology for Wellness Industries. 1, 4 (Jan. 2013), 235–240. DOI:https://doi.org/10.6000/1927-3037.2012.01.04.3.